Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group. (Q54117576)
Jump to navigation
Jump to search
scientific article published in February 1994
Language | Label | Description | Also known as |
---|---|---|---|
English | Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group. |
scientific article published in February 1994 |
Statements
Docetaxel in advanced renal carcinoma. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group. (English)
W C Mertens
E A Eisenhauer
J Jolivet
S Ernst
M Moore
A Muldal
1 February 1994
5
2
185-187